Wallace Advisory Group, LLC Bristol Myers Squibb CO Transaction History
Wallace Advisory Group, LLC
- $124 Billion
- Q3 2025
A detailed history of Wallace Advisory Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wallace Advisory Group, LLC holds 6,746 shares of BMY stock, worth $315,780. This represents 0.25% of its overall portfolio holdings.
Number of Shares
6,746
Previous 8,128
17.0%
Holding current value
$315,780
Previous $496 Million
37.01%
% of portfolio
0.25%
Previous 0.36%
Shares
11 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...